SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AMBROSIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.651
AS - Asia 11.179
EU - Europa 7.897
SA - Sud America 1.784
Continente sconosciuto - Info sul continente non disponibili 385
AF - Africa 229
OC - Oceania 19
Totale 44.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.019
SG - Singapore 4.290
CN - Cina 2.692
DE - Germania 2.322
IT - Italia 1.788
BR - Brasile 1.399
VN - Vietnam 1.224
HK - Hong Kong 895
UA - Ucraina 863
GB - Regno Unito 590
RU - Federazione Russa 545
TR - Turchia 497
FI - Finlandia 476
BD - Bangladesh 403
FR - Francia 368
CA - Canada 281
JP - Giappone 277
SE - Svezia 260
IN - India 241
PL - Polonia 228
MX - Messico 198
ID - Indonesia 144
AR - Argentina 134
NL - Olanda 122
ZA - Sudafrica 88
IQ - Iraq 85
PK - Pakistan 72
ES - Italia 70
EC - Ecuador 62
CO - Colombia 59
VE - Venezuela 46
UZ - Uzbekistan 43
LT - Lituania 42
MY - Malesia 42
BE - Belgio 39
AT - Austria 38
PH - Filippine 37
SA - Arabia Saudita 31
CR - Costa Rica 28
JM - Giamaica 28
MA - Marocco 28
AE - Emirati Arabi Uniti 26
CL - Cile 24
IE - Irlanda 22
TN - Tunisia 21
KE - Kenya 18
PE - Perù 18
AL - Albania 17
AU - Australia 17
EG - Egitto 16
HN - Honduras 16
JO - Giordania 16
TT - Trinidad e Tobago 16
PY - Paraguay 15
NP - Nepal 14
BO - Bolivia 13
RO - Romania 13
TH - Thailandia 13
AZ - Azerbaigian 12
CH - Svizzera 12
DZ - Algeria 12
PS - Palestinian Territory 12
UY - Uruguay 12
IL - Israele 11
SV - El Salvador 11
CZ - Repubblica Ceca 10
ET - Etiopia 10
LB - Libano 10
GR - Grecia 9
GT - Guatemala 9
KR - Corea 9
KZ - Kazakistan 9
PT - Portogallo 9
CY - Cipro 8
AM - Armenia 7
IR - Iran 7
LV - Lettonia 7
OM - Oman 7
PA - Panama 7
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
EU - Europa 6
KG - Kirghizistan 6
NI - Nicaragua 6
PR - Porto Rico 6
DK - Danimarca 5
GA - Gabon 5
HU - Ungheria 5
MD - Moldavia 5
MT - Malta 5
NG - Nigeria 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BY - Bielorussia 4
EE - Estonia 4
GP - Guadalupe 4
HR - Croazia 4
KW - Kuwait 4
Totale 43.694
Salva come PNG Salva come JPEG
Città #
Singapore 2.748
Ashburn 2.514
San Jose 1.697
Woodbridge 1.318
Fairfield 1.156
Chandler 1.111
Santa Clara 955
Jacksonville 907
Hong Kong 881
Beijing 878
Council Bluffs 840
Houston 825
Ann Arbor 506
Seattle 449
New York 447
Wilmington 443
Los Angeles 427
Ho Chi Minh City 401
Dallas 362
Cambridge 359
Munich 318
Hanoi 297
Izmir 281
Tokyo 266
Nanjing 265
Milan 246
Princeton 229
Warsaw 218
Addison 216
Lauterbourg 215
Helsinki 196
São Paulo 171
Ferrara 165
San Diego 160
Shanghai 157
Mexico City 133
Phoenix 122
Rome 121
Boardman 116
Orem 103
Chicago 101
Buffalo 98
London 97
Toronto 97
Atlanta 96
Turku 91
Jakarta 89
Denver 80
Washington 79
Brooklyn 78
Shenyang 78
San Francisco 76
Chennai 74
Hebei 70
Montreal 70
Nanchang 70
Hefei 69
Bremen 67
Tianjin 58
Dearborn 56
Bologna 54
Johannesburg 54
Changsha 52
Frankfurt am Main 52
Moscow 52
Haiphong 50
Stockholm 50
Boston 46
Da Nang 46
Mountain View 46
Jiaxing 43
Manchester 41
Rio de Janeiro 40
Falls Church 37
Naples 37
Poplar 37
The Dalles 37
Brussels 36
Tashkent 36
Redwood City 35
Jinan 33
Kunming 33
Nuremberg 32
Amsterdam 31
Guangzhou 31
Hải Dương 31
Baghdad 29
Belo Horizonte 29
Ankara 27
Biên Hòa 27
Lahore 27
Philadelphia 26
Mumbai 25
Quito 25
Ningbo 24
Brasília 23
Charlotte 23
Norwalk 23
Des Moines 22
New Delhi 22
Totale 26.237
Salva come PNG Salva come JPEG
Nome #
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 1.135
Pituitary and COVID-19 vaccination: a systematic review 515
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 342
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 320
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 293
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 285
Circadian profile of plasma calcitonin gene-related peptide in healthy man 262
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 260
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 253
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 252
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 251
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 249
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 247
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 244
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 244
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 238
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 238
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 236
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 236
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 233
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 232
The mystery of Mont’e Prama: sculptures, acromegaly, and nuragic society 231
Growth hormone induces chemoresistance in breast cancer cells 230
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 229
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 228
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 227
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 226
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 224
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 223
Growth hormone excess promotes breast cancer chemoresistance 223
Antiproliferative effects of somatostatin analogs in pituitary adenomas 221
A new VHL polymorphism in a big family from Ferrara 217
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 217
Diurnal rhythm of plasma catecholamines in acromegaly 216
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 215
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 214
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 213
Neck paraganglioma and follicular lymphoma: A case report 213
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 213
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 209
A tool to predict survival in stage IV entero-pancreatic NEN 209
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 208
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 208
Percutaneous Laser Ablation of Liver Metastases from Neuroendocrine Neoplasm. A Retrospective Study for Safety and Effectiveness 207
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 206
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 205
Efficacy, safety and adherence to treatment of teriparatide: an observational study 203
Effects of octreotide on gallbladder motor function in acromegaly 203
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 202
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 201
Glucose metabolism alterations in acromegaly 199
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 199
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 199
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 198
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 197
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 197
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 195
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 194
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 194
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 194
In vitro testing of new somatostatin analogs on pituitary tumor cells 193
Pituitary side effects of old and new drugs. 193
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 193
Growth hormone and skeletal muscle function 192
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 192
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 191
Functional hypothalamic and drug-induced amenorrhea: an overview 191
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 190
Cerebral aneurysm and acromegaly: a case report 190
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 190
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 189
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 188
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 188
ASSE GH-IGF-I NELL'INVECCHIAMENTO 188
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 188
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 187
Densitometria Ossea (DEXA): come interpretarla evitando le trappole 187
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 186
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI) 186
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 185
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 185
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 184
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 184
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 183
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 183
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 182
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 180
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 179
Acromegaly in the elderly patients 178
Delta opioid receptor involvement in endocrine pathophysiology 177
Alcohol use disorders and liver fibrosis: an update 176
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 176
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 176
Le alterazioni pressorie nell'acromegalia: fattori umorali 176
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 176
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 175
Real-time PCR is useful to detect menin gene deletions 174
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 173
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro 173
Sistema Simpatoadrenomidollare nei pazienti acromegalici 173
Totale 22.122
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 14.082
Totale 207.567
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.601 0 0 0 57 89 90 96 90 79 162 187 751
2022/20232.357 234 221 90 310 328 341 127 205 282 26 119 74
2023/20241.350 108 142 73 41 102 263 48 150 45 30 31 317
2024/20255.557 157 149 427 183 640 580 206 198 906 687 782 642
2025/202616.268 1.472 611 1.302 1.891 2.491 1.124 1.955 910 1.486 1.783 770 473
2026/20275.286 1.315 1.619 1.669 683 0 0 0 0 0 0 0 0
Totale 44.144